Medicare Enrolled

Dr. Hugo Fonseca, D.O.

Rheumatology · Pembroke Pines, FL
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
160 S FLAMINGO RD, Pembroke Pines, FL 33027
9546200011
Registered in NPPES since 2010
NPI: 1841519980 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Fonseca from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Fonseca? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Fonseca

Dr. Hugo Fonseca is a rheumatology specialist in Pembroke Pines, FL, with 16 years of NPI registration. Based on federal Medicare data, Dr. Fonseca performed 1,706 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Dr. Fonseca received a total of $17,479 from 42 pharmaceutical and/or device companies across 828 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Fonseca is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 16 years of NPI registration ▲ 1,706 Medicare services $17,479 industry payments

Florida License Status

FL DOH · MQA
1
Active license
None
Board action on record
0
Recent admin complaints
Profession License # Status Expires Board Action
Osteopathic Physician 10973 Clear March 31, 2028
Data from Florida Department of Health Medical Quality Assurance. License records are public under Chapter 119, Florida Statutes. Verify directly on FL DOH →

Medicare Practice Summary — 2023

Medicare Utilization ↗
1,706
Medicare services
Bottom 36% in FL for rheumatology
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
Not available
Unique patients (not deduplicated)
$29
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Denosumab injection (Prolia/Xgeva) 1,440 $19 $30
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
142 $91 $193
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
53 $120 $252
Non-hormonal chemotherapy injection
This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue.
30 $58 $120
Joint injection, major joint
Removal of fluid from a large joint and/or injection of medication into the joint space.
26 $50 $128
Injection, methylprednisolone acetate, 40 mg 15 $5 $11
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.

Industry Payment Transparency

Open Payments through 2024 ↗
$17,479
Total received (2018-2024)
Avg $2,497/year across 7 years
Top 28% in FL for rheumatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
42
Companies
828
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$4,767
2023
$4,569
2022
$4,652
2021
$1,882
2020
$1,026
2019
$318
2018
$265

Payments by company (2024)

Amgen Inc.
$697
Janssen Biotech, Inc.
$641
Mallinckrodt Hospital Products Inc.
$582
ABBVIE INC.
$541
UCB, Inc.
$434
Aurinia Pharma U.S., Inc.
$336
Lilly USA, LLC
$241
PFIZER INC.
$234
ANI Pharmaceuticals, Inc.
$198
AstraZeneca Pharmaceuticals LP
$173
E.R. Squibb & Sons, L.L.C.
$141
Radius Health, Inc.
$101
GlaxoSmithKline, LLC.
$100
DePuy Synthes Sales Inc.
$100
SOBI, INC
$55
Kyowa Kirin, Inc.
$42
Fresenius Kabi USA, LLC
$32
Alvogen Inc
$32
Octapharma USA, Inc.
$25
Boehringer Ingelheim Pharmaceuticals, Inc.
$24
Kiniksa Pharmaceuticals International, plc
$20
Novartis Pharmaceuticals Corporation
$18
Top 3 companies account for 40.3% of 2024 payments
All-time payments by company (2018-2024) ›
Amgen Inc.
$2,786
UCB, Inc.
$1,659
Mallinckrodt Hospital Products Inc.
$1,440
Janssen Biotech, Inc.
$1,430
ABBVIE INC.
$1,148
Lilly USA, LLC
$1,059
AstraZeneca Pharmaceuticals LP
$958
Aurinia Pharma U.S., Inc.
$850
Novartis Pharmaceuticals Corporation
$814
PFIZER INC.
$795
GlaxoSmithKline, LLC.
$573
Horizon Therapeutics plc
$506
Radius Health, Inc.
$403
AbbVie Inc.
$388
ANI Pharmaceuticals, Inc.
$329
E.R. Squibb & Sons, L.L.C.
$325
Octapharma USA, Inc.
$188
GENZYME CORPORATION
$183
Organon LLC
$173
DePuy Synthes Sales Inc.
$145
Boehringer Ingelheim Pharmaceuticals, Inc.
$145
Alexion Pharmaceuticals, Inc.
$128
Alvogen Inc
$126
Genentech USA, Inc.
$118
Actelion Pharmaceuticals US, Inc.
$117
AbbVie, Inc.
$95
SOBI, INC
$75
Mylan Institutional Inc.
$69
GRT US Holding, Inc.
$64
Kyowa Kirin, Inc.
$62
Hikma Pharmaceuticals USA
$59
Flexion Therapeutics, Inc.
$39
Kiniksa Pharmaceuticals, Ltd.
$39
Boston Scientific Corporation
$38
Fresenius Kabi USA, LLC
$32
Regeneron Healthcare Solutions, Inc.
$25
Ultragenyx Pharmaceutical Inc.
$24
Kiniksa Pharmaceuticals International, plc
$20
Pacira Pharmaceuticals Incorporated
$14
Kowa Pharmaceuticals America, Inc.
$13
Pacira Therapeutics, Inc.
$13
TerSera Therapeutics LLC
$12
Top 3 companies account for 33.7% of all-time payments
Associated products mentioned in payments ›
ACTHAR · AMJEVITA · AVSOLA · Actemra · Arcalyst · BENLYSTA · Bimzelx · COSENTYX · Cimzia · Crysvita · EVENITY · Enbrel · HADLIMA · HUMIRA · Hulio · Humira · ILARIS · Iovera · KEVZARA · KINERET · KRYSTEXXA · LUPKYNIS · Mitigare · NEXPLANON · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OFEV · OPSUMIT · ORENCIA · ORTHOVISC · Otezla · PENNSAID · PURIFIED CORTROPHIN GEL · Qutenza · Quzyttir · REMICADE · RENFLEXIS · RINVOQ · Rinvoq · Rituxan · SAPHNELO · SIMPONI ARIA · SKYRIZI · SOVUNA · STRENSIQ · Seglentis · Strensiq · TALTZ · TAVNEOS · TEPEZZA · TERIPARATIDE · TREMFYA · Tavneos · Tymlos · UPTRAVI · VELSIPITY · XELJANZ · Zilretta
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a rheumatology specialist in Pembroke Pines?
Compare rheumatologists in the Pembroke Pines area by procedure volume, costs, and industry payment transparency.
Browse rheumatologists nearby

Geographic Context

Rheumatologists in nearby ZIP areas
94
County median income
$74,534
Nearest hospital to ZIP centroid (approximate)
MEMORIAL HOSPITAL WEST
1.8 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Fonseca is a mixed practice specialist, with moderate Medicare volume, with 16 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Fonseca experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Fonseca performed 1,440 denosumab injection (prolia/xgeva) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Fonseca receive payments from pharmaceutical companies?
Yes. Dr. Fonseca received a total of $17,479 from 42 companies across 828 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Fonseca's costs compare to other rheumatologists in Pembroke Pines?
Dr. Fonseca's average Medicare payment per service is $29. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Fonseca) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →